Axelrod, Mark J <br/><br/>
Synergistic apoptosis in head and neck squamous cell carcinoma cells by co-inhibition of insulin-like growth factor-1 receptor signaling and compensatory signaling pathways.  [electronic resource] 

 -  Head & neck  Dec 2015 
 - 1722-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0347 
<br/><br/><label>Standard No.: </label>10.1002/hed.23822  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Carbamates--administration & dosage<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cell Culture Techniques<br/>Cell Line, Tumor<br/>Dasatinib--administration & dosage<br/>Drug Resistance, Neoplasm<br/>Drug Synergism<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Phosphorylation--drug effects<br/>Proto-Oncogene Proteins c-akt--drug effects<br/>Pyrazoles--administration & dosage<br/>Receptor, IGF Type 1--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Triazines--administration & dosage